B cell receptor signaling and downstream NF-κB activity are crucial for the maturation and functionality of all major B cell subsets, yet the molecular players in these signaling events are not fully understood. Here we use several genetically modified mouse models to demonstrate that expression of the multifunctional BRCT (BRCA1 C-terminal) domain-containing PTIP (Pax transactivation domain-interacting protein) chromatin regulator is controlled by B cell activation and potentiates steady-state and postimmune antibody production in vivo. By examining the effects of PTIP deficiency in mice at various ages during ontogeny, we demonstrate that PTIP promotes bone marrow B cell development as well as the neonatal establishment and subsequent long-term maintenance of self-reactive B-1 B cells. Furthermore, we find that PTIP is required for B cell receptor-and T:B interaction-induced proliferation, differentiation of follicular B cells during germinal center formation, and normal signaling through the classical NF-κB pathway. Together with the previously identified role for PTIP in promoting sterile transcription at the Igh locus, the present results establish PTIP as a licensing factor for humoral immunity that acts at several junctures of B lineage maturation and effector cell differentiation by controlling B cell activation.
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antibody | B cell biology | B-1 | IgM | immunodeficiency T he full spectrum of vertebrate humoral antibody immunity is made up of natural antibodies and postimmune antigenspecific antibodies (1) . Natural antibodies are produced by innate-like B-1 cells enriched for reactivities to carbohydrate moieties found on common microbial pathogens as well as selfglycolipids and play an established role in immune surveillance and the clearance of cellular debris (2) . Together with marginal zone (MZ) B cells, B-1 cells also mount rapid thymus-independent (TI) antibody responses against blood-borne pathogens and provide an important first line of defense during early stages of infection (3, 4) . The far more prevalent follicular (FO) B-2 B cell subset, on the contrary, undergoes T-dependent (TD) affinity maturation and antibody class-switch recombination (CSR) in germinal centers (GCs) of secondary lymphoid organs to provide high-affinity IgG responses during the later stages of infection as well as immunological memory. Together, the different B cell subsets perform nonredundant functions to provide optimal host defense.
The PTIP protein is a ubiquitously expressed, nuclear-localized chromatin regulator containing six BRCT (BRCA1 C-terminal) domains. It has been described as an adaptor protein and is implicated in gene regulation, DNA replication, and DNA repair (5) . Even though PTIP associates with the MLL3/MLL4 methyltransferase complex, it also has the capacity to function in gene expression independently from this complex (6) and in DNA repair with the 53BP1 protein (7) . In B cells, PTIP is required for sterile transcription of switch regions at the Ig heavy-chain (Igh) locus and subsequent IgH CSR to multiple IgG isotypes in a manner independent from MLL3/MLL4 (6, 8, 9 ). Here we use mouse genetics to demonstrate that PTIP additionally establishes steady-state and postimmune IgM and IgG antibody production in vivo by regulating the development, activation, and survival of B cell subsets, at least in part, via the classical NF-κB signaling pathway.
Results

PTIP Is Required for Antibody Production in Vivo.
PTIP is known to facilitate IgH class-switching in stimulated B cells ex vivo (6, 8) . To begin to determine the role of PTIP in antibody responses in vivo, we immunized CD19 cre/+ PTIP flox/flox (referred to here as PTIP −/− ) mice and assayed antigen-specific antibody levels from serum over a 3-wk period. We used TNP-LPS as a TI type 1 antigen, TNP-Ficoll as a TI type 2 antigen, and TNP-KLH as a TD antigen. Serum from PTIP −/− mice harbored a near-complete block in the levels of TNP-specific IgG3 after immunization compared with CD19 cre/+ PTIP +/+ controls (referred to as WT) at 7 d postimmunization ( Fig. 1 A-C, Right), in line with previous ex vivo findings (6, 8) . IgG1 and IgG2b responses were similarly altered in PTIP −/− mice ( Fig. S1 A-C).
Significance
To provide optimal host defense, the full spectrum of antibodybased immunity requires natural antibodies and immunizationinduced antigen-specific antibodies. Here we show that the PTIP (Pax transactivation domain-interacting protein) chromatin regulator is induced by B cell activation to potentiate the establishment of steady-state and postimmune serum antibody levels. It does so by promoting activation-associated proliferation and differentiation of all the major B cell subsets, at least in part, through regulating the NF-κB pathway. With the genetic basis still unknown for a majority of patients with common variable immunodeficiency, further work investigating how PTIP controls cell signaling may generate valuable new insight for human health and disease.
Interestingly, PTIP −/− mice showed impaired levels of TNPspecific IgM across the three different immunization schemes, ranging from 2.8-to 14-fold decreases at 7 d postimmunization, suggesting a physiological role beyond regulation of CSR ( Fig.  1 A-C, Left) . We conclude that PTIP promotes antigenspecific IgM and IgG responses in vivo, despite being largely dispensable for the development of most splenic B cells (8) (Fig. S1D) .
In view of the profound impairments in antibody responses to TI and TD antigens in PTIP-deficient mice, we examined GC formation in these mice. Mice were immunized with the TD antigen sheep red blood cells (SRBCs) and GC B cells were assayed from spleens. At 6 and 10 d postimmunization, PTIP −/− mice displayed severely impaired frequencies and numbers of GC (CD19 +
B220
+ PNA + CD95 + ) B cells compared with control mice (Fig. 1 D and E) . Consistent with IgG1 class-switching defects associated with PTIP deficiency (6, 8) (Fig. S1 A-C), IgG1 + frequencies were also impaired among GC B cells in SRBC-immunized PTIP −/− mice compared with controls ( Fig. 1F  and Fig. S1E ). We conclude that PTIP promotes TD GC B cell differentiation after immunization in vivo.
To determine antibody levels at steady state, we analyzed serum from unimmunized animals. We found that PTIP −/− mice displayed a 7.6-fold decrease in serum IgM levels in addition to severely reduced IgG1, IgG2a, IgG2b, and IgG3 levels (Fig. 1G) . At steady state, IgM antibodies are highly enriched for specificities against carbohydrate moieties such as phosphorylcholine (PC) and serve an important function in immune surveillance and the removal of cellular debris (2) . To determine whether the decrease in steady-state serum IgM levels from PTIP −/− mice was linked to a deficiency in such protective natural antibodies, we measured PC-specific IgM titers and observed a 10-fold decrease (Fig. 1G) . Thus, PTIP critically potentiates steady-state and postimmune levels of IgM and IgG antibodies in vivo.
PTIP harbors DNA repair functions that are, at least in part, mediated by its physical association with 53BP1 (7); however, consistent with other reports (10, 11), we found decreased IgG1 but normal total IgM in the serum of 53BP1 −/− mice (Fig.  1H ). In addition, PC-specific IgM levels from 53BP1 −/− mice were indistinguishable from those from controls (Fig. 1H) . Furthermore, even though antigen-specific IgG3 levels were severely impaired upon challenging 53BP1 −/− mice with the TI type 2 TNP-Ficoll antigen, we found antigen-specific IgM to be indistinguishable vs. controls (Fig. S1F) . These results suggest that PTIP promotes natural and antigen-induced IgM levels independently from its association with 53BP1 and its involvement in DNA repair. 
PTIP Deficiency Causes a Partial
CD19
+ IgM + CD24 − ) B cells in the bone marrow were concomitantly increased 1.9-fold and 1.5-fold, respectively, comparable to controls (Fig. 2 A and B) . We conclude that loss of PTIP leads to a mild B cell development defect marked by an inefficient transition of large cycling Fig. 1 . PTIP is required for steady-state and antigeninduced antibody production in vivo. Mice were immunized with (A) TNP-LPS, (B) TNP-Ficoll, or (C) TNP-KLH, and anti-TNP-specific IgM or IgG3 serum levels were measured by ELISA at the indicated days before and after immunization. Data are from four mice of each genotype in A, four mice in B, and seven mice in C, and are plotted as Ig concentration or the absorbance for the serum dilution that gave half optical density (mean ± SEM). Experiments were repeated at least two times. P values at 7 d after immunization are as follows: (A) IgM, *P = 0.03; IgG3, ****P < 0.0001; (B) IgM, *P = 0.02; IgG3, ***P = 0.0003; (C) IgM, ***P = 0.001; IgG3, ****P < Day 6, ***P = 0.0005; day 10, ****P < 0.0001; PBS vs. day 6 in WT, ****P < 0.0001. (G) ELISA analysis of total Ig levels from sera of unimmunized mice. Data are from at least six mice of each genotype and are presented as mean ± SEM. IgG1, *P = 0.015; IgG2a, ***P = 0.001; IgG2b, **P = 0.005; IgG3, **P = 0.004; IgM, **P = 0.002; anti-PC IgM, ***P = 0.0006. (H) ELISA analysis of total Ig levels from sera of unimmunized mice. Data are from at least six mice of each genotype and are presented as mean ± SEM. IgG1, *P = 0.046; others not significant (ns). Statistics were generated by using a two-tailed unpaired t test with Welch's correction. ) cell numbers were decreased by 9.6-fold compared with control mice (Fig. 2G) . In stark contrast, the numbers of conventional B (CD19
) cells in the peritoneal cavity were indistinguishable vs. control mice (Fig. 2G) . A similar decrease in B-1a cell numbers was observed in the spleen ( (Fig. 1) .
To better understand the requirement for PTIP protein in various B cell subsets, we measured PTIP expression at the single-cell level by using a previously described knock-in mouse model that expresses GFP-tagged PTIP under the control of its endogenous regulatory elements (PTIP gfp/gfp ) (6). Interestingly, PTIP-GFP protein levels were higher in the B-1a, B-1b, and MZ B cell populations compared with conventional B-2 cells (Fig. 2  H and I) . Together with the GC defects, these results from innate-like B cells are consistent with a functional requirement for PTIP in cells that have a strong dependency on BCRmediated signals for maturation and maintenance.
PTIP Is Required for Neonatal B Cell Maturation. With B cell development in the bone marrow only being mildly reduced, possibly leading to a slower establishment of mature conventional B cell pools, the profound loss of B-1 cells and natural IgM in mice lacking PTIP remained curious. To better understand the reason for such immunodeficiency, we further investigated B-1a cell maturation in greater detail. Shortly after birth, rapid accumulation of B-1a cells in the peritoneal cavity (Fig. 3A) coincides with the increase in total and PC-specific serum IgM levels, as seen in 3-wk-old WT mice (Fig. 3 B and C) . Strikingly, only a negligible increase in B-1a cell numbers are found in PTIP −/− peritoneal cavities throughout ontogeny, and natural antibody titers remain flat-lined (Fig. 3 A-C and Fig. S3A) .
B-1a cells are not efficiently generated in adult life and sustain their peripheral presence through bone marrow-independent self-maintenance (14) . To assess if a maturation defect could contribute to the observed decrease in B-1a cell representation in PTIP-deficient mice, we analyzed transitional B cells from spleens of neonatal mice known to efficiently give rise to B-1a B cells (15 Fig. 3 D and E) . Similar results were obtained for mature (CD93 − B220 + ) B cells, and results were also similar at 2 d of age (Fig. 3 D-F) . Remarkably, by 2 wk of age and later in adult mice as described earlier (Fig. 2 C and D) , these splenic B cell maturation defects were no longer apparent (Fig. 3 D-F PTIP-Deficient B-1a Cells Are Unable to Maintain Long-Term Survival of Self-Reactive Clones. B-1a cells are enriched for self-reactive specificities and rely mainly on self-antigen driven survival to maintain their peripheral population through life (12) . The most common BCR specificity among B-1a cells is directed toward the self-glycolipid phosphatidylcholine (PtC) (17, 18) exposed on the surface of damaged cells. In light of the observed defects in neonatal B-1a cell development, we sought to understand whether the failure of B-1a cells to accumulate and establish a sizable population in PTIP-deficient mice is a consequence of an inability to produce a self-reactive BCR repertoire. To this end, we performed high-throughput Igh-μ repertoire analysis by (variable, diversity, joining) deep sequencing (VDJ-Seq) of the residual peritoneal cavity B-1a cell populations in 5-and 8-wk-old PTIP −/− mice (as shown in Fig. 2F and Fig. S3A ). Upon extraction of the identities and frequencies of CDR3 clonotypes, we found the B-1a repertoire of 5-wk-old PTIP −/− mice to harbor comparable frequencies of PtC-reactive CDR3s vs. age-matched controls (Fig.  4 A and B and Fig. S3B ). This result demonstrates that bona fide B1a specificities can be generated in the absence of PTIP. Strikingly, the representation of this specificity is markedly decreased in 8-wkold PTIP −/− mice, evident by a trend toward decreased usage of the VH12 segment known to encode the PtC specificity and an increased usage of VH4 (Fig. 4 A-C) . Thus, although PTIPdeficient mice can successfully generate a small number of B-1a cells with the appropriate self-reactive BCR specificities, these clones fail to be maintained through self-antigen driven positive selection. Thus, the apparent lack of B-1a cells in adult PTIP −/− mice may be a compound effect from defects in B-1a cell maturation (Fig. 3) and peripheral maintenance.
To establish a direct role of PTIP in mature B-1a cell survival and maintenance in vivo without the influence of bone marrow influx, we FACS sorted PTIP −/− and control B-1a cells from 5-wk-old mice and transplanted equal numbers intraperitoneally into RAG1 −/− recipient mice. Two weeks after transplantation, markedly fewer B cells remained in recipients of PTIP −/− cells compared with controls (Fig. 4D) . This survival defect could be recapitulated upon in vitro culturing in media, in which PTIP −/− B-1a cells from 5-wk-old mice were found to have a reduced frequency of live Annexin V − DAPI − cells after 48 h (Fig. 4E) . Consistent with these results, we measured the expression of the antiapoptotic BCL2 gene and found it to be significantly reduced at the mRNA and protein levels in PTIP −/− B-1a cells compared with controls ( Fig. 4F and Fig. S4A ). We conclude that PTIP promotes B-1a cell survival and is associated with increased BCL2 expression.
To formally rule out any developmental influence on B-1a cell survival, we crossed PTIP flox/flox mice with a mouse strain expressing tamoxifen (TAM)-inducible Cre-ERT2 to assess the effects of TAMinduced deletion of PTIP expression. In adult mice, bone marrowdependent influx into the B-1a compartment is low; therefore, any observed phenotypes in the immediate weeks following TAM treatment of adult mice can be attributed to changes in the functionality of mature B-1a cells rather than developmental consequences. To visualize the frequency of Cre recombinase-expressing cells in these mice, we crossed in the Rosa26-stop-YFP Cre-reporter allele to generate Cre-ERT2 , herein referred to as WT). Upon validating efficient Cre-mediated deletion (Fig. S4 B-D) , we observed that several in vivo phenotypes of PTIP −/− mice were also recapitulated following inducible PTIP deletion. First, a significant decrease in the frequency of B-1a but not B-2 B cells could be observed among YFP + peritoneal cavity cells of PTIP Δ/Δ mice after TAM administration (Fig. 4 G and H and Fig. S4E ). Second, within the B-1a cell gate, frequencies of VH12 + and PtC liposome + cells were decreased in YFP + cells of PTIP Δ/Δ mice ( Fig. 4I and Fig.  S4F ), consistent with PTIP being required for self-antigen driven peripheral maintenance (Fig. 4 A-C) . Finally, YFP + B-1a cells from treated PTIP Δ/Δ mice displayed decreased BCL2 expression compared with controls ( Fig. 4J and Fig. S4G ). Taken together, these results formally establish a crucial role for PTIP in the survival of adult B-1a cells that is distinct from any developmental effects of PTIP deficiency.
PTIP Is Required for B Cell Activation via the NF-κB Pathway. To elucidate the molecular function of PTIP, we subjected sorted B-1a cells from 5-wk-old PTIP −/− and control animals to microarray-based global analyses of gene expression changes. In total, PTIP-deficient B-1a cells revealed 137 genes whose expression was down-regulated and 78 genes whose expression was up-regulated by at least twofold (Dataset S1). Interestingly, many differentially expressed genes were associated with signal transduction in the immune system, indicative of a role for PTIP in regulating signaling events (Fig. 5A) . To further investigate this notion, we screened for the expression of a panel of proteins known to play a role in B-1a cell signaling by FACS. Although many of these did not change (CD19, BAFFR, and IL5RA; Fig.  S5A ), a few notable proteins were differentially expressed in the absence of PTIP. These include decreased Ceacam1/CD66a (Fig.  5B) and FcγRIIB (Fig. S5A ), which were identified by the microarray, as well as increased CD72 (Fig. 5C ) and CD22, and decreased CD43 and Siglec-G (Fig. S5A) . Notably, Ceacam1 promotes signaling through the canonical NF-κB pathway (19) , whereas CD72 can oppose it (20) . Furthermore, the microarray identified an increase in the mRNA levels of Anxa1, encoding Annexin A1, a negative regulator of canonical NF-κB signaling (21, 22) (Dataset S1). Increased Annexin A1 was validated at the protein level by intracellular FACS in B-1a, B-1b, and B-2 B cells (Fig. 5D) . These findings are intriguing in lieu of the crucial role of the NF-κB pathway in promoting B-1 and MZ B cell development as well as B cell survival through the regulation of Bcl2 family members (23, 24) . To further investigate a potential role of PTIP in NF-κB signaling, we measured the expression of NF-κB proteins in freshly isolated PTIP −/− B-1a cells from 5-wk-old mice. These analyses revealed decreased intracellular levels of cREL (Fig. 5 E and F) along with NF-κB targets urokinase plasminogen activator (uPA) and IRF4 (Fig. S5A) , suggesting that the absence of PTIP may perturb the classical NF-κB pathway and thereby lead to the observed impairments in the B-1 population.
The molecular program of steady-state B-1 cells often shares characteristics with that of their activated FO B-2 counterparts (2). Thus, we hypothesized that, even though PTIP only subtly reduces FO B-2 numbers at steady state (Fig. 2 D and E) , it may regulate their function upon activation. Consistent with this notion, we found PTIP protein expression in mature splenic B cells cultured for 3 d to be increased 2.5-fold, 3.6-fold, or 5.2-fold upon anti-CD40, LPS, or BCR cross-linking, respectively, by using PTIP gfp/gfp mice ( Fig. 5G  and Fig. S5B ). To directly assess the role of PTIP in BCR-induced FO B-2 B cell activation, we first measured cell proliferation by way of carboxyfluorescein N-hydroxysuccinimidyl ester (CFSE) dilution. Strikingly, proliferation of PTIP −/− splenic B cells was entirely abrogated in response to stimulation with anti-IgM antibody (Fig. 5H and Fig. S5C) , with fewer cells undergoing active DNA replication as measured by EdU incorporation (Fig. S5D ). An impairment in proliferation was also observed in PTIP −/− B cells in response to anti-CD40 (Fig. 5H and Fig. S5C ). Interestingly, LPS and the TLR9 ligand CpG oligonucleotide stimulations induced extensive proliferation in WT and PTIP −/− B cells, although the fraction of B cells that underwent activation-induced proliferation was subtly decreased in the absence of PTIP (Fig. 5H and Fig. S5 C and D) .
Survival of PTIP
−/− B cells was reduced by 2.4-fold upon stimulation with anti-IgM antibody but was less affected in response to other stimulations (Fig. S5E) . Together, these data suggest that PTIP is required for specific aspects of B-2 cell activation downstream of antigen-and T:B interaction-induced activation rather than general cell cycle progression. Consistent with this notion, stimulated PTIP −/− B cells showed reduced cell surface expression of the CD86 activation marker in vitro and in vivo following antiIgM stimulation and SRBC immunization, respectively (Fig. S6 A  and B) . These results indicate a crucial role for induced PTIP protein levels in propagating molecular events downstream of BCR ligation.
To identify signaling pathways that might be altered in PTIPdeficient FO B-2 B cells, we performed intracellular FACS analyses for phosphorylation events triggered by BCR crosslinking. We found no differences with respect to phospho-S6 (Fig. S6C) , phospho-ERK (Fig. S6D) , phospho-JNK (Fig. S6E) , or phospho-SYK (Fig. S6F) , consistent with normal membraneproximal signaling and activation of the PI3K/AKT/mTOR and MAPK pathways. We did, however, detect significantly decreased protein expression of cREL (Fig. 5I and Fig. S6G ) and the NF-κB target genes NFATc1, BCLXL, and BCL2 in PTIP −/− B cells (Fig. S6 G and H) . These results constitute further evidence that the classical NF-κB pathway is impaired in the absence of PTIP. Consistent with these data, we observed elevated levels of IκBα in both freshly isolated and anti-IgM-stimulated FO B-2 B cells from PTIP −/− mice (Fig. S6I) . The classical and the alternative NF-κB pathways are activated in B cells when stimulated with anti-CD40 antibody (25, 26) . To determine whether PTIP also regulates the alternative NF-κB pathway, we interrogated the expression of RELB and its target gene PIM2 in anti-CD40 stimulated PTIP −/− and control B cells. Although we again observed decreased cREL expression, RELB and PIM2 were unchanged ( Fig. 5J and Fig. S6J ). Altogether, these results demonstrate a requirement for PTIP in promoting signaling via the classical NF-κB pathway in steady-state B-1a cells and FO B-2 B cells in response to BCR or CD40 engagement, providing an explanation for the apparent lack of postimmune antibody and GC responses upon TI and TD immunizations (Fig. 1) .
Discussion
In this study, we use mouse genetics to establish a crucial role for PTIP in licensing the humoral arm of the adaptive immune system in vivo, through regulating key activation and signaling events critical for multiple aspects of B cell development and function (Fig. 6) . By using a PTIP-GFP knock-in mouse model, we demonstrate that cellular levels of PTIP protein correlate with BCR signaling strength, being elevated in steady-state innate-like B cell subsets and stimulated FO B cells. By using mice that lack PTIP in a B cell-specific manner, we show a partial block in B cell development at the pre-B cell stage, a severe impairment in neonatal B-1a cell maturation, and defective GC B cell differentiation. In addition, we find that sustained PTIP expression in adult mice is required to promote the long-term maintenance of bona fide self-reactive B-1a cells. Although the steady-state numbers of splenic B-2 cells are not markedly reduced in PTIP-deficient mice, these cells fail to undergo BCR or CD40 stimulation-induced proliferation, at least in part, because of a defect in the classical NF-κB pathway. These results significantly expand the list of PTIP-dependent B cell functions beyond promoting sterile transcription at the Igh locus and CSR (6, 8, 9) and indicate a key role for PTIP in activation-associated proliferation, survival, and differentiation triggered by antigen engagement and T:B interaction. Consequently, PTIP deficiency results in severe hypo-IgM, hypogammaglobulinemia, and profoundly blunted antibody responses to TD and TI antigen immunization, hallmarks of primary common variable immunodeficiency (CVID).
Although the precise molecular targets by which PTIP mediates its function in B cell signaling remain to be elucidated, we provide multiple lines of evidence in PTIP-deficient B-1a cells and activated B-2 B cells for deregulation of the classical NF-κB pathway. In addition to decreased cREL and increased IκBα at steady state and in response to anti-IgM, we find protein levels of a handful of NF-κB target genes to be decreased in PTIP-deficient B cells, including BCL2, BCLXL (27, 28) , NFATc1 (29) , uPA, IRF4 (30) , and CD23 (31) . These findings indicate a requirement for PTIP in the classical NF-κB pathway and are in line with (i) the established role of the NF-κB pathway in B-1 cell development (15, 24, 25, 32) , (ii) evidence for a role of NF-κB downstream of pre-BCR signaling in small pre-B cells (28, (33) (34) (35) (36) , and (iii) FO B-2 cell functionality including activation-induced proliferation, survival, antibody production, GC differentiation, and CSR (24) (25) (26) 37) . Although the role of NF-κB signaling in the development of FO B cells may primarily be to promote BCL2 or BCLXL expression for antiapoptotic effects (27, 28, 34) , evidence suggests that BCL2-independent functions of NF-κB play a major role in B-1, MZ, and GC B cells and hint at prominent roles during activationassociated differentiation (24, 27, 37) . Considering that the cREL NF-κB protein plays an important role in antigen-mediated BCR activation (38) and that sustained cREL activation in response to BCR signaling requires de novo cREL transcription (39), we speculate that PTIP may function in the activation and/or expression of this protein. Several other PTIP-regulated genes have also previously been shown to influence the NF-κB pathway including CD72 (20, 40) , Ceacam1 (19) , and Annexin A1 (21, 22) . Future studies aimed at determining the contribution of each of these signaling components to the various junctures of PTIP involvement in B cell biology (Fig. 6 ) will be needed to map the PTIP-dependent genetic program establishing humoral immunity.
The striking lack of steady-state levels of serum IgM in PTIPdeficient mice despite normal numbers of overall splenic B cells correlates with the combined loss of B-1 and MZ B cells. These innate-like B cell subsets act in concert to mediate the majority of TI antibody production (2-4), and their development differs from FO B-2 cells in their increased dependency on BCR signaling. For example, B-1a and MZ B cells are positively selected on self-antigen during maturation and their unique clonal representation depends on continued self-antigen exposure (12, 13, 17) . Indeed, numerous mouse models deficient in B-1 cells show concomitant defects in MZ B cells (3, 25) , including those harboring perturbations in BCR signaling and the NF-κB pathway. We speculate that the B-1 and MZ B cell defects associated with PTIP deficiency stem from a common impairment in signaling and manifest together as a general reduction in natural and postimmune IgM levels. Furthermore, the aforementioned characteristics of innate-like B cells along with the observed higher PTIP protein levels in B-1 and MZ B cells compared with FO B cells are consistent with PTIP protein expression being positively regulated by BCR signaling. Similarly, the elevated expression of and reliance on PTIP protein during neonatal B lymphopoiesis hint toward elevated BCR signaling early in life.
PTIP is a multifunctional chromatin regulator known to dynamically contribute to several multimeric protein complexes to regulate transcription and DNA repair in response to changes in cellular demand (5) . A common denominator for our observed PTIP functions in humoral immunity, including the previously described regulation of sterile transcription at the Igh locus (6, 8) , is that they operate independently from its interaction with the 53BP1 DNA repair protein. Consistent with this, perturbations of other DNA damage response factors do not impact steady-state or postimmune IgM responses. Moreover, B cells lacking PTIP do not have an inherent defect in cell cycle progression. Thus, we speculate that PTIPdependent transcriptional regulation rather than its involvement in DNA repair/replication is responsible for the observed effects on humoral immunity. Although MLL4 complexes containing PTIP have been shown to regulate B cell gene expression, phenotypic differences between PTIP-and MLL4-deficient mice (6, 41, 42) point toward an MLL4-independent role for PTIP in humoral immunity.
Although much remains to be understood about how PTIP is regulated by, and in turn regulates, BCR and T:B interaction-triggered molecular events, a model is emerging in which PTIP fundamentally controls humoral immunity at multiple junctures of B cell development and differentiation (ii) efficient differentiation of small pre-B cells in response to pre-BCR signaling during B cell development; (iii) facilitating signal transduction in response to BCR engagement to promote B cell activation and proliferation/survival, contributing to TI production of antigen-specific IgM during the initial phase of the antibody response; (iv) facilitating signal transduction in response to CD40/CD40L engagement to promote B cell activation and proliferation upon cognate T cell-B cell interaction including GC B cell differentiation; and (v) activating sterile transcription at "switch regions" within the Igh locus to promote IgG class-switching. Ag, antigen; Prog, progenitor; T H , helper T cell. Gray dots signify self-antigens; red dots signify foreign antigens. (Fig. 6) . Our results place PTIP in a molecular node required for B cell activation important for humoral immune responses in health and disease. CVID is the most prevalent primary antibody deficiency; with a highly heterogeneous disease origin, the genetic abnormality remains unknown in a majority of patients (43) . Further work investigating the mechanism of PTIP function in this context and how it controls the NF-κB pathway may generate valuable new insight.
Materials and Methods
Bone marrow and spleens were subjected to RBC lysis. Antibodies are detailed in Table S1 . FACS experiments on freshly isolated cells used a DAPI negative live lymphocyte gate. Intracellular staining experiments used the Zombie Aqua fixable viability kit (BioLegend). Cells were acquired on BD LSRFortessa and sorted on a BD FACSAria III Cell Sorter. All other methods are described in SI Materials and Methods.
